Decellularized Cartilage Powder Scaffold for Osteochondral Repair
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cartilage repair techniques face challenges in effectively treating osteochondral defects due to the poor intrinsic healing ability of articular cartilage and limitations in existing stimulation and replacement strategies, including inferior mechanical qualities of fibrocartilage and donor site morbidity.
Innovation Solution
Decellularized cartilage tissue powder is used as a raw material for scaffolds, providing a microenvironment similar to native cartilage, which is chondroinductive and stimulates bone marrow stem cell responses, including cell attachment, differentiation, and tissue regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If stimulation techniques are used to bring mesenchymal progenitors to differentiate and repopulate the defect, then short-term results are improved, but the repair tissue eventually fails due to inferior structural and mechanical qualities
Solution Approach 1:
The patent applies preliminary action by pre-processing cartilage tissue through decellularization before implantation. The decellularized cartilage matrix is prepared in advance to provide a scaffold that guides proper tissue regeneration, ensuring both short-term viability and long-term mechanical strength by establishing the correct structural framework before cells are introduced
Solution Approach 2:
The decellularized cartilage matrix serves as an intermediary between the defect site and the regenerating tissue. This intermediate scaffold provides the necessary structural support and biochemical cues that guide mesenchymal progenitor cells to differentiate into hyaline cartilage, bridging the gap between initial cell recruitment and final tissue maturation with proper mechanical properties
2Duration of action of stationary object
If replacement strategies using autologous cartilage are used to fill the defect, then long-term durability is improved, but donor site-associated morbidity and tissue scarcity occur
Solution Approach 1:
The patent applies the extraction principle by removing cells from donor cartilage tissue while retaining the extracellular matrix. This separation allows the matrix to be used as a scaffold for regeneration without requiring harvesting additional tissue from the donor site, eliminating donor site morbidity while preserving the long-term durability benefits of autologous tissue
Solution Approach 2:
The patent changes the state of the cartilage tissue from living tissue to decellularized matrix through chemical and physical processing. This parameter change transforms the tissue into a scaffold that maintains the biochemical and structural properties necessary for long-term durability while eliminating the need for additional donor tissue harvesting
3Manufacturing precision
If synthetic polymer components are used to form hydrogels or porous matrices for scaffolds, then scaffold structural control is improved, but the microenvironment similarity to native cartilage is reduced
Solution Approach 1:
The patent creates a composite material by combining the structural control of processed cartilage matrix with the biochemical authenticity of native extracellular matrix components. The decellularized cartilage scaffold integrates collagen fibers, proteoglycans, and other native matrix elements in their natural hierarchical arrangement, providing both manufacturing precision and microenvironment similarity
4Reliability
If decellularized cartilage powder is used as a raw material for scaffolds, then chondroinductive properties are improved, but the complexity of the decellularization process increases
Solution Approach 1:
The patent applies segmentation by dividing the cartilage tissue into smaller particles or powder form during the decellularization process. This segmentation increases the surface area for chemical reagent penetration, enabling more efficient and thorough decellularization while preserving the chondroinductive properties of the extracellular matrix components
Data Source
AI summary
The present invention is related to compositions comprising decellularized cartilage tissue powder in the forms of paste, putty, hydrogel, and scaffolds, methods of making compositions, and methods of using these compositions for treating osteochondral defects and full- or partial-thickness cartilage defects.


